Secondary : Actualité Secondary en direct - P1 | Bourse Reflex
Accueil > Tags > Secondary

  • Toutes les actualités en rapport avec « Secondary »

26/04 18:00 Secondary - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

23/04 07:30 Secondary - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:00 Secondary - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

18/10 15:00 Secondary - MIDCAP PARTNERS: Co-Lead Manager in a 120M EUR placement of Solutions 30 shares

10/07 20:00 Secondary - Artprice: reaction to the article in Countrepoint: A Historic Attack on the Art Market!

30/06 13:05 Secondary - Artprice takes a major stake in the OTC Art Market which generates a volume of transactions roughly 7 to 9 times higher than the traditional art market

31/05 08:30 Secondary - Artprice fits perfectly into President Macron's Digital Europe Project

30/01 18:00 Secondary - BUSINESS UPDATE - FOURTH QUARTER 2016

13/12 18:30 Secondary - GENTICEL REPORTS FINAL RESULTS OF GTL001 PHASE 2 TRIAL IN HPV16/18-INFECTED WOMEN

27/09 19:00 Secondary - METabolic EXplorer in the 1st half of 2016: Progress in the development of L-Methionine

29/07 15:00 Secondary - Artprice: after recovering top position, is China preparing the final attack with Sotheby's - addendum to Artprice's H1 Art Martket report.

25/07 11:20 Secondary - Artprice.com: Defying all forecasts... China upped 18%, dominated the global Art Market in the first half of 2016

21/07 18:00 Secondary - Implementation of share buy-back programme as agreed by July 20th 2016 AGM

23/06 17:45 Secondary - GENTICEL REPORTS 18 MONTH INTERIM ANALYSIS OF GTL001 PHASE 2 TRIAL IN HPV16/18 INFECTED WOMEN

20/04 18:30 Secondary - GENTICEL REPORTS ADDITIONAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

08/03 07:00 Secondary - FIGEAC AERO WELCOMES NEW INVESTORS

27/01 18:40 Secondary - GENTICEL REPORTS INITIAL RESULTS AT 12 MONTHS FROM PHASE 2 TRIAL OF HPV IMMUNOTHERAPEUTIC CANDIDATE, GTL001

18/01 00:40 Secondary - Preview for Artprice's Global Art Market Annual Report (2015) available exclusively through (AFP) Agence France Presse on 2 February 2016

05/10 19:30 Secondary - Artprice's 2014/15 Contemporary Art Market Report: +1,800% turnover in 15 years

23/07 18:05 Secondary - Description of the share buy-back programme approved by the AGM of 22 July 2015